Kathryn E. Falberg

2013

In 2013, Kathryn E. Falberg earned a total compensation of $2.7M as Former Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals, a 34% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$380,000
Option Awards$890,560
Salary$472,693
Stock Awards$946,080
Other$3,622
Total$2,692,955

Falberg received $946.1K in stock awards, accounting for 35% of the total pay in 2013.

Falberg also received $380K in non-equity incentive plan, $890.6K in option awards, $472.7K in salary and $3.6K in other compensation.

Rankings

In 2013, Kathryn E. Falberg's compensation ranked 2,874th out of 12,286 executives tracked by ExecPay. In other words, Falberg earned more than 76.6% of executives.

ClassificationRankingPercentile
All
2,874
out of 12,286
77th
Division
Manufacturing
958
out of 4,612
79th
Major group
Chemicals And Allied Products
252
out of 1,466
83rd
Industry group
Drugs
170
out of 1,160
85th
Industry
Pharmaceutical Preparations
140
out of 890
84th
Source: SEC filing on June 10, 2015.

Falberg's colleagues

We found four more compensation records of executives who worked with Kathryn E. Falberg at Jazz Pharmaceuticals in 2013.

2013

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2013

Suzanne Hooper

Jazz Pharmaceuticals

General Counsel

2013

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

2013

Fintan Keegan

Jazz Pharmaceuticals

Executive Vice President, Technical Operations

You may also like